African-American Heart Failure Trial

• Status: Completed
• Trial end date: 2004-08-01
• Target enrollment: 0
• Participant gender: All

Summary

A placebo-controlled trial of BiDil added to standard therapy in African-American patients with heart failure.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nitromed

Criteria

• African American male or female 18 years or older.

• NYHA Class 3 & 4.

• Have either a resting LVEF less than or equal to 35% (by any method) or a resting LVIDD greater than 2.9 cm/m2 BSA (or greater than 6.5 cm) with LVEF less than 45% (by echocardiogram).